NVO - Employee benefits survey finds marked increase in GLP-1 coverage
2024-06-14 18:24:23 ET
More on Eli Lilly, Novartis, etc.
- Eli Lilly: The Road To Approval Of Donanemab Is Open
- Eli Lilly and Company (LLY) Goldman Sachs 45th Annual Global Healthcare Conference
- Is It Possible Eli Lilly Is Breaking Out To New All-Time Highs?
- Employer coverage for GLP-1s rising amid FDA label expansions: survey
- Lilly's Retevmo gains traditional approval in thyroid cancer